Healthcare provider profile · identity verified

Danice Blaise, MD,MBA

General Practice · LAKE WALES, FL · NPI 1255829966

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	622	226
Metformin Hcl	Metformin Hcl	275	96
Furosemide	Furosemide	233	82
Lisinopril	Lisinopril	228	84
Amlodipine Besylate	Amlodipine Besylate	223	86
Gabapentin	Gabapentin	206	76
Albuterol Sulfate Hfa	Albuterol Sulfate	200	65
Losartan Potassium	Losartan Potassium	186	64
Methylprednisolone	Methylprednisolone	165	123
Levothyroxine Sodium	Levothyroxine Sodium	164	54
Vitamin D2	Ergocalciferol (Vitamin D2)	137	49
Chlorthalidone	Chlorthalidone	124	36
Pantoprazole Sodium	Pantoprazole Sodium	122	46
Hydrochlorothiazide	Hydrochlorothiazide	118	41
Glimepiride	Glimepiride	113	36
Metoprolol Succinate	Metoprolol Succinate	109	37
Omeprazole	Omeprazole	102	34
Potassium Chloride	Potassium Chloride	101	40
Tamsulosin Hcl	Tamsulosin Hcl	97	35
Tramadol Hcl	Tramadol Hcl	94	40
Eliquis	Apixaban	91	25
Clopidogrel	Clopidogrel Bisulfate	86	31
Naproxen	Naproxen	83	45
Trazodone Hcl	Trazodone Hcl	83	27
Alprazolam	Alprazolam	82	20
Metoprolol Tartrate	Metoprolol Tartrate	81	30
Rosuvastatin Calcium	Rosuvastatin Calcium	77	27
Famotidine	Famotidine	74	25
Ibuprofen	Ibuprofen	69	26
Montelukast Sodium	Montelukast Sodium	69	24
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	67	50
Azithromycin	Azithromycin	65	53
Pioglitazone Hcl	Pioglitazone Hcl	65	28
Glipizide	Glipizide	64	24
Ozempic	Semaglutide	64	20
Levofloxacin	Levofloxacin	62	47
Tizanidine Hcl	Tizanidine Hcl	60	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	58	19
Alendronate Sodium	Alendronate Sodium	57	17
Carvedilol	Carvedilol	57	20
Allopurinol	Allopurinol	54	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	28
Fluoxetine Hcl	Fluoxetine Hcl	52	19
Mounjaro	Tirzepatide	51	14
Baclofen	Baclofen	48	17
Finasteride	Finasteride	48	20
Sertraline Hcl	Sertraline Hcl	48	16
Sucralfate	Sucralfate	46	17
Citalopram Hbr	Citalopram Hydrobromide	45	13
Jardiance	Empagliflozin	45	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	44	33
Doxycycline Monohydrate	Doxycycline Monohydrate	43	41
Meloxicam	Meloxicam	40	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	12
Duloxetine Hcl	Duloxetine Hcl	38	13
Buspirone Hcl	Buspirone Hcl	37	12
Fluticasone Propionate	Fluticasone Propionate	36	14
Simvastatin	Simvastatin	34	11
Testosterone Cypionate	Testosterone Cypionate	33	11
Hydroxyzine Hcl	Hydroxyzine Hcl	32	11
Advair Hfa	Fluticasone Propion/Salmeterol	30	suppressed
Entresto	Sacubitril/Valsartan	30	suppressed
Lorazepam	Lorazepam	30	suppressed
Meclizine Hcl	Meclizine Hcl	30	17
Ondansetron Hcl	Ondansetron Hcl	28	22
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Nitroglycerin	Nitroglycerin	25	12
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Pregabalin	Pregabalin	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Atenolol	Atenolol	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Loperamide	Loperamide Hcl	19	16
Symbicort	Budesonide/Formoterol Fumarate	19	11
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	13
Midodrine Hcl	Midodrine Hcl	17	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Methimazole	Methimazole	14	suppressed
Ofloxacin	Ofloxacin	14	12
Tolterodine Tartrate	Tolterodine Tartrate	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Linzess	Linaclotide	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Topiramate	Topiramate	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error